Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Revenue 2018–2025
Bionexus Gene Lab Corp. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Bionexus Gene Lab Corp. revenue for the quarter ending March 31, 2026 was 22842, a 98.93% decrease year-over-year.
- Bionexus Gene Lab Corp. revenue for the twelve months ending March 31, 2026 was 7.0 M, a 27.01% decrease year-over-year.
- Bionexus Gene Lab Corp. annual revenue for 2025 was 7.4 M, a 21.93% decrease from 2024.
- Bionexus Gene Lab Corp. annual revenue for 2024 was 9.5 M, a 2.66% decrease from 2023.
- Bionexus Gene Lab Corp. annual revenue for 2023 was 9.8 M, a 10.60% decrease from 2022.
- Bionexus Gene Lab Corp. annual revenue for 2022 was 10.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bionexus Gene Lab Corp. Revenue — FAQ
Bionexus Gene Lab Corp. (BGLC) revenue over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Bionexus Gene Lab Corp.'s revenue?
Bionexus Gene Lab Corp. (BGLC) reported revenue of $7M for fiscal 2025.
Where can I see BGLC's revenue history?
The chart and table above show Bionexus Gene Lab Corp.'s revenue by year and by quarter, including the growth rate.